Regulatory
Key facts
FDA approved Mimrylo (rusfertide) for adults with polycythemia vera
Key facts
Polycythemia vera is described as a rare blood disorder that causes the body to make too…
Key facts
Excess red blood cells can thicken the blood and increase cardiovascular risks
Atlas Watchline
The FDA has approved Mimrylo (rusfertide) for adults with polycythemia vera, a rare blood disorder that…